Walden Group Healthcare M&A Blog

  • Patient Square Capital to Acquire Hanger for $1.2b

    Hanger, Inc. (NYSE: HNGR), a $1.14b provider of orthotic and prosthetic (O&P) patient care services and devices, announced that it will be taken private by Patient Square Capital, a private investment firm.  Hanger operates 875 clinic locations nationwide and distributes branded and private label O&P devices. Deal value - $1.25b on sales...
    Read More
  • BD (Becton, Dickinson and Company) Completes $1.5b Acquisition of Parata Systems

    Parata Systems adds a portfolio of pharmacy automation solutions that reduce costs, enhance patient safety and improve patient experience for retail, hospital and long-term care pharmacies.  The pharmacy automation market is worth an estimated $600 million and is expected to grow approximately 10% annually to $1.5 billion in the U.S. alone over...
    Read More
  • OrthoPediatrics to Acquire Pega Medical

    OrthoPediatrics, a $98m producer of implants and devices that treat orthopedic conditions in children, is acquiring Canada-based Pega Medical, a developer of implant systems that treat bony deformities in children with osteogenesis imperfecta (brittle bone disease), for $33m.  The acquisition adds to OrthoPediatrics’ range of technologies...
    Read More
  • Biosynth Carbosynth Acquires Aalto Bio Reagents

      Biosynth Carbosynth, a provider of life science research products and contract manufacturing services, has purchased Ireland-based Aalto Bio Reagents, a supplier of biological materials serving the in-vitro diagnostic (IVD) and vaccine development markets.  In March 2022, Biosynth acquired vivitide, a provider of custom peptides and...
    Read More
  • The Walden Group Releases Q1 2022 Strategic Healthcare M&A Report

    The Walden Group is pleased to provide access to its Q1 2022 Strategic Healthcare M&A Report, which includes:       Market Overview       Major M&A Deals by Sector       What the Leading CEOs are Saying       Performance of Leading Healthcare Companies       Analysis of More Than 50 Q1 M&A...
    Read More